Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Preventive cardiovascular recommendations].
Galán AM, Cuixart CB, Álvarez FV, Pérez JN, Lobos-Bejarano JM, Sánchez-Pinilla RO, Rioboó EM, Banegas Banegas JR, Orozco-Beltrán D, Guillén VG; Grupo de Prevención Cardiovascular del Programa de Actividades Preventivas y de Promoción de la Salud. Galán AM, et al. Aten Primaria. 2012 Jun;44 Suppl 1(Suppl 1):3-15. doi: 10.1016/S0212-6567(12)70010-0. Aten Primaria. 2012. PMID: 23399503 Free PMC article. Spanish. No abstract available.
[Evidence-based anti-platelet treatment: PAPPS recommendations].
Brotons Cuixart C, Lobos Bejarano JM, Martín Rioboó E, Galán AM; Grupo de Prevención Cardiovascular del Programa de Actividades Preventivas y de Promoción de la Salud (PAPPS). Brotons Cuixart C, et al. Among authors: galan am. Aten Primaria. 2012 Dec;44(12):734-6. doi: 10.1016/j.aprim.2012.07.004. Epub 2012 Sep 13. Aten Primaria. 2012. PMID: 22980944 Free PMC article. Spanish. No abstract available.
Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy Volunteers.
Arellano-Rodrigo E, Lopez-Vilchez I, Galan AM, Molina P, Reverter JC, Carné X, Villalta J, Tassies D, Lozano M, Díaz-Ricart M, Escolar G. Arellano-Rodrigo E, et al. Among authors: galan am. Transfus Med Rev. 2015 Oct;29(4):242-9. doi: 10.1016/j.tmrv.2015.08.001. Epub 2015 Aug 8. Transfus Med Rev. 2015. PMID: 26364029 Clinical Trial.
Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death.
Ill-Raga G, Palomer E, Ramos-Fernández E, Guix FX, Bosch-Morató M, Guivernau B, Tajes M, Valls-Comamala V, Jiménez-Conde J, Ois A, Pérez-Asensio F, Reyes-Navarro M, Caballo C, Gil-Gómez G, Lopez-Vilchez I, Galan AM, Alameda F, Escolar G, Opazo C, Planas AM, Roquer J, Valverde MA, Muñoz FJ. Ill-Raga G, et al. Among authors: galan am. Biochim Biophys Acta. 2015 Mar;1852(3):421-8. doi: 10.1016/j.bbadis.2014.12.007. Epub 2014 Dec 12. Biochim Biophys Acta. 2015. PMID: 25500153 Free article.
Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating human blood.
Escolar G, Arellano-Rodrigo E, Lopez-Vilchez I, Molina P, Sanchis J, Reverter JC, Carne X, Cid J, Villalta J, Tassies D, Galan AM, Diaz-Ricart M. Escolar G, et al. Among authors: galan am. Circ J. 2015;79(2):331-8. doi: 10.1253/circj.CJ-14-0909. Epub 2014 Dec 8. Circ J. 2015. PMID: 25482382 Free article.
58 results